Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirogabalin in MRM
NCT07880821Not yet recruiting
- Sponsor
- Cairo University
- Start
- Oct 2026
- Primary completion
- Jul 2027
01
Overview
Randomised, double-blind trial in postoperative pain comparing Mirogabalin Group with Placebo Group (2 arms). Primary endpoint: Total Postoperative Morphine Consumption During the First 24 Hours. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
mirogabalin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07880821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07880821.